Correlation of the change in the International Normalized Ratio and decreasing the coumadin dosage following total joint arthroplasty

Orthopedics

Volumn 25, Issue 12, 2002, Pages 1359-1363

  Rosenbaum, Cathy Creger ^a   Woods, Scott E ^b   Hasselfeld, Kimberly A ^b  

^a Bethesda North Hospital   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN K GROUP; WARFARIN;

ADULT; AGE; AGED; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DOSE RESPONSE; FEMALE; HIP FRACTURE; HUMAN; INTERNATIONAL STANDARD UNIT; KNEE DISEASE; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PILOT STUDY; POSTOPERATIVE THROMBOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURGICAL PATIENT; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROTHROMBIN TIME; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; VENOUS THROMBOSIS; WARFARIN;

EID: 0036929152     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Swayze OS, Nasser S, Roberson JR. Deep venous thrombosis in total hip arthroplasty. Orthop Clin North Am. 1992; 23: 359-364.
2. Ginsberg JS, Turkstra F, Buller HR, MacKinnon B, Magier D, Hirsh J. Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study. Arch Intern Med. 2000; 160:669-672.
3. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001; 119(1 Suppl):132S-175S.
4. Hull RD, Raskob GE, Ginsberg JS, et al. A noninvasive strategy for the treatment of patient with suspected pulmonary embolism Arch Intern Med. 1994; 154:289-297.
5. Moser KM, Fedullo PF, LitteJohn JK, Crawford R. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA. 1994; 271:223-225.
6. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary emolism in patients with treated venous thromboembolism. JAMA. 1998; 279;458-462.
7. Freedman KB, Brookkenthal KR, Fitzgerald RH Jr., Williams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am. 2000; 82:929-938.
8. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer De. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA. 1998; 279:657-662.
9. Angelo S, Nardino RJ. Comparing 5-mg and 10-mg warfarin loading doses: are the groups similar? Arch Intern Med. 1999; 159:1624-1625.
10. Harrison L, Johnston M, Massicotte MP, Crowther M, Moffat K, Hirsh J. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med. 1997; 126:133-136.
11. O'Connell MB, Kowal PR, Allivato CJ, Repka TL. Evaluation of warfarin initiation regimens in elderly inpatients. Pharmacotherapy. 2000; 20:923-930.
12. Messieh M, Huang Z. Johnson LJ, Jobin S. Warfarin responses in total joint and hip fracture patients. J Arthroplasty. 1999; 14:724-729.
13. Whtie RH, Hong R, Venook AP, et al. Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing. J Gen Intern Med. 1987; 2:141-148.
14. Poller L, Wright D, Rowlands M. Prospective comparative study of computer programs used for management of warfarin. J Clin Pathol. 1993; 46:299-303.
15. Svec JM, Coleman RW, Mungall DR, Ludden TM. Bayesian pharmacokinetic/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluation. Ther Drug Monit. 1985; 7:174-180.
16. Dalere GM, Coleman RW, Lum BL. A graphic nomogram for warfarin dosage adjustment. Pharmacotherapy. 1999; 19:461-467.
17. Motykie GD, Mokhtee D, Zebala LP, Caprini JA, Kudrna JC, Mungall DR. The use of a Bayesian forecasting model in the management of warfarin therapy after total hip arthroplasty. J Arthroplasty. 1999; 14:988-993.
18. White RH, Mungall D. Outpatient management of warfarin therapy: comparison of computer-predicted dosage adjustment to skilled professional care. Ther Drug Monit. 1991; 13:46-50.
19. Ansell J, Hirsh J, Dalen J, et al. Managing oral anticoagulant therapy. Chest. 2001; 119(1 Suppl): 22S-38S.
20. Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 1995; 108(4 Suppl):231S-246S.
21. Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000; 57:1221-1227.
22. Caprini JA, Arcelus JI, Motykie G, Kudrna JC, Mokhtee D, Reyna JJ. The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement. J Vasc Surg. 1999; 30:813-820.